Literature DB >> 7437708

An index for monitoring bone metastases from carcinoma of the prostate.

J G Hardy, A E Kulatilake, M L Wastie.   

Abstract

The bone uptake of 99Tcm-methylene diphosphonate has been monitored quantitatively in patients undergoing treatment for carcinoma of the prostate. The uptake is expressed as a function of the administered dose. The results show that oestrogen therapy has no significant effect on the uptake into normal bone. Case reports are presented illustrating the use of the technique.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437708     DOI: 10.1259/0007-1285-53-633-869

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  2 in total

1.  Serial radionuclide imaging during treatment of patients with diffuse bone metastases from carcinoma of the prostate.

Authors:  A C Perkins; J G Hardy; M L Wastie; K M Clifford
Journal:  Eur J Nucl Med       Date:  1982

2.  Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy.

Authors:  G M Sundkvist; L Ahlgren; B Lilja; S Mattsson; P A Abrahamsson; L B Wadström
Journal:  Eur J Nucl Med       Date:  1988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.